Skip to main content
Top
Published in: Diabetologia 11/2008

01-11-2008 | Article

Biological and behavioural explanations of social inequalities in coronary heart disease: the Whitehall II study

Authors: M. G. Marmot, M. J. Shipley, H. Hemingway, J. Head, E. J. Brunner

Published in: Diabetologia | Issue 11/2008

Login to get access

Abstract

Aims/hypothesis

We determined the degree to which metabolic syndrome components, inflammation and health behaviours account for the social gradient in CHD.

Methods

A total of 5312 men, initially aged 39 to 63 years, were followed for 13.1 years for incident coronary death or non-fatal myocardial infarction according to socioeconomic position (employment grade). The contribution of explanatory factors to socioeconomic differences in CHD was assessed by the reduction in hazard ratios computed using Cox models. The effects of measurement error were taken into account.

Results

Coronary events were more common in lower employment grades than in higher, with a hazard ratio (relative index of inequality) of 2.2 (95% CI 1.3–3.7), after adjustment for age and ethnic group. Behavioural risk factors (mainly smoking and diet) explained a third of the socioeconomic gradient in CHD incidence. Components of the metabolic syndrome and inflammatory markers predicted CHD incidence and also explained a third of the gradient. Combined, these two groups of predictors, i.e. behavioural and biological, accounted for over half of the socioeconomic gradient in incident CHD. Adding body height as a marker of the effects of early life increased this figure to about 60%.

Conclusions/interpretation

A major question has been how someone’s socioeconomic position can lead to increased risk of CHD. Socioeconomic differences in components of the metabolic syndrome (and inflammatory markers) provide part of the answer. This was, to an important degree, independent of the contribution of health behaviours to the socioeconomic differentials in CHD.
Literature
1.
go back to reference Drever F, Whitehead M (1997) Health inequalities: decennial supplement. Series DS No. 15 Stationery Office, Office for National Statistics, London, pp 1–257 Drever F, Whitehead M (1997) Health inequalities: decennial supplement. Series DS No. 15 Stationery Office, Office for National Statistics, London, pp 1–257
2.
go back to reference No authors listed (1998) Health, United States, 1998 socioeconomic status and health chartbook. US Department of Health and Human Services No authors listed (1998) Health, United States, 1998 socioeconomic status and health chartbook. US Department of Health and Human Services
3.
go back to reference Marmot MG, Shipley MJ, Rose G (1984) Inequalities in death—specific explanations of a general pattern. Lancet 323:1003–1006CrossRef Marmot MG, Shipley MJ, Rose G (1984) Inequalities in death—specific explanations of a general pattern. Lancet 323:1003–1006CrossRef
4.
go back to reference Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S (1997) Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet 350:235–239PubMedCrossRef Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S (1997) Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet 350:235–239PubMedCrossRef
5.
go back to reference Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen JT (1996) Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 144:934–942PubMed Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen JT (1996) Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 144:934–942PubMed
6.
go back to reference Kunst AE, Groenhof F, Mackenbach JP, The EU Working Group on Socioeconomic Inequalities in Health (1998) Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies. BMJ 316:1636–1638PubMed Kunst AE, Groenhof F, Mackenbach JP, The EU Working Group on Socioeconomic Inequalities in Health (1998) Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies. BMJ 316:1636–1638PubMed
7.
go back to reference Diez Roux AV, Merkin SS, Arnett D et al (2001) Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 345:99–106PubMedCrossRef Diez Roux AV, Merkin SS, Arnett D et al (2001) Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 345:99–106PubMedCrossRef
8.
go back to reference Adler N, Ostrove J (1999) Socioeconomic status and health: What we know and what we don’t. In: Adler N, Marmot M, McEwen B, Stewart J (eds) Socioeconomic status and health in industrial nations. New York Academy of Sciences, New York, pp 3–15 Adler N, Ostrove J (1999) Socioeconomic status and health: What we know and what we don’t. In: Adler N, Marmot M, McEwen B, Stewart J (eds) Socioeconomic status and health in industrial nations. New York Academy of Sciences, New York, pp 3–15
9.
go back to reference van Rossum CTM, Shipley MJ, Van de Mheen H, Grobbee DE, Marmot MG (2000) Employment grade differences in cause specific mortality. A 25 year follow up of civil servants from the first Whitehall study. J Epidemiol Community Health 54:178–184PubMedCrossRef van Rossum CTM, Shipley MJ, Van de Mheen H, Grobbee DE, Marmot MG (2000) Employment grade differences in cause specific mortality. A 25 year follow up of civil servants from the first Whitehall study. J Epidemiol Community Health 54:178–184PubMedCrossRef
10.
go back to reference Emberson JR, Whincup PH, Morris RW, Walker M (2004) Social class differences in coronary heart disease in middle-aged British men: implications for prevention. Int J Epidemiol 33:289–296PubMedCrossRef Emberson JR, Whincup PH, Morris RW, Walker M (2004) Social class differences in coronary heart disease in middle-aged British men: implications for prevention. Int J Epidemiol 33:289–296PubMedCrossRef
11.
go back to reference Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L (2006) Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 332:878–882PubMedCrossRef Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L (2006) Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 332:878–882PubMedCrossRef
12.
go back to reference Brunner EJ, Marmot MG, Nanchahal K et al (1997) Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 40:1341–1349PubMedCrossRef Brunner EJ, Marmot MG, Nanchahal K et al (1997) Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 40:1341–1349PubMedCrossRef
13.
go back to reference Gimeno D, Brunner EJ, Lowe GDO, Rumley A, Marmot MG, Ferrie JE (2007) Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur J Epidemiol 22:677–683CrossRef Gimeno D, Brunner EJ, Lowe GDO, Rumley A, Marmot MG, Ferrie JE (2007) Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur J Epidemiol 22:677–683CrossRef
14.
go back to reference Marmot MG, Davey Smith G, Stansfeld SA et al (1991) Health inequalities among British Civil Servants: the Whitehall II study. Lancet 337:1387–1393PubMedCrossRef Marmot MG, Davey Smith G, Stansfeld SA et al (1991) Health inequalities among British Civil Servants: the Whitehall II study. Lancet 337:1387–1393PubMedCrossRef
15.
16.
go back to reference Brunner EJ, Stallone D, Juneja M, Bingham S, Marmot M (2001) Dietary assessment in Whitehall II: comparison of 7d diet diary and food frequency questionnaire and validity against biomarkers. Br J Nutr 86:405–414PubMedCrossRef Brunner EJ, Stallone D, Juneja M, Bingham S, Marmot M (2001) Dietary assessment in Whitehall II: comparison of 7d diet diary and food frequency questionnaire and validity against biomarkers. Br J Nutr 86:405–414PubMedCrossRef
17.
go back to reference Martikainen P, Brunner E, Marmot M (2003) Socioeconomic differences in dietary patterns among middle-aged men and women. Soc Sci Med 56:1397–1410PubMedCrossRef Martikainen P, Brunner E, Marmot M (2003) Socioeconomic differences in dietary patterns among middle-aged men and women. Soc Sci Med 56:1397–1410PubMedCrossRef
18.
go back to reference Brunner EJ (1997) Socioeconomic determinants of health: stress and the biology of inequality. BMJ 314:1472–1476PubMed Brunner EJ (1997) Socioeconomic determinants of health: stress and the biology of inequality. BMJ 314:1472–1476PubMed
19.
go back to reference World Health Organization (1977) International classification of diseases—9th revision. World Health Organization, Geneva World Health Organization (1977) International classification of diseases—9th revision. World Health Organization, Geneva
20.
go back to reference Rose G, Hamilton PJS, Colwell L, Shipley MJ (1982) A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 36:102–108PubMed Rose G, Hamilton PJS, Colwell L, Shipley MJ (1982) A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 36:102–108PubMed
21.
go back to reference Macfarlane PW, Devine PW, Latif S, McLaughlin S, Shoat DB, Watts MP (1990) Methodology of ECG interpretation in the Glasgow program. Methods Inform Med 29:354–361 Macfarlane PW, Devine PW, Latif S, McLaughlin S, Shoat DB, Watts MP (1990) Methodology of ECG interpretation in the Glasgow program. Methods Inform Med 29:354–361
22.
go back to reference Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583–612PubMed Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583–612PubMed
23.
go back to reference Kunst AE, Mackenbach JP (1994) The size of mortality differences associated with educational level in nine industrialized countries. Am J Public Health 84:932–937PubMed Kunst AE, Mackenbach JP (1994) The size of mortality differences associated with educational level in nine industrialized countries. Am J Public Health 84:932–937PubMed
24.
go back to reference Sergeant JC, Firth D (2006) Relative index of inequality: definition, estimation, and inference. Biostatistics 7:213–224PubMedCrossRef Sergeant JC, Firth D (2006) Relative index of inequality: definition, estimation, and inference. Biostatistics 7:213–224PubMedCrossRef
25.
go back to reference Hardin JW, Schmiediche H, Carroll RJ (2003) The regression calibration method for fitting generalized linear models with additive measurement error. The Stata Journal 8:361–372 Hardin JW, Schmiediche H, Carroll RJ (2003) The regression calibration method for fitting generalized linear models with additive measurement error. The Stata Journal 8:361–372
26.
go back to reference Davey Smith G, Lynch J (2004) Life course approaches to socioeconomic differentials in health. In: Kuh D, Ben Shlomo Y (eds) A life course approach to chronic disease epidemiology. 2nd edn. OUP, Oxford, pp 77–115 Davey Smith G, Lynch J (2004) Life course approaches to socioeconomic differentials in health. In: Kuh D, Ben Shlomo Y (eds) A life course approach to chronic disease epidemiology. 2nd edn. OUP, Oxford, pp 77–115
27.
go back to reference Kumari M, Marmot M, Brunner E (2000) Social determinants of von Willebrand factor: the Whitehall II study. Arterioscler Thromb Vasc Biol 20:1842–1847PubMed Kumari M, Marmot M, Brunner E (2000) Social determinants of von Willebrand factor: the Whitehall II study. Arterioscler Thromb Vasc Biol 20:1842–1847PubMed
28.
go back to reference Brunner EJ, Davey Smith G, Marmot MG, Canner R, Beksinska M, O'Brien J (1996) Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 347:1008–1013PubMedCrossRef Brunner EJ, Davey Smith G, Marmot MG, Canner R, Beksinska M, O'Brien J (1996) Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 347:1008–1013PubMedCrossRef
29.
go back to reference Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397PubMedCrossRef Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397PubMedCrossRef
30.
go back to reference Timpson NJ, Lawlor DA, Harbord RM et al (2005) C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 366:1954–1959PubMedCrossRef Timpson NJ, Lawlor DA, Harbord RM et al (2005) C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 366:1954–1959PubMedCrossRef
31.
go back to reference Casas JP, Shah T, Cooper J et al (2006) Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35:922–931PubMedCrossRef Casas JP, Shah T, Cooper J et al (2006) Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35:922–931PubMedCrossRef
32.
go back to reference Stephens JW, Hurel SJ, Lowe GD, Rumley A, Humphries SE (2007) Association between plasma IL-6, the IL6-174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus. Mol Genet Metab 90:422–428PubMedCrossRef Stephens JW, Hurel SJ, Lowe GD, Rumley A, Humphries SE (2007) Association between plasma IL-6, the IL6-174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus. Mol Genet Metab 90:422–428PubMedCrossRef
33.
go back to reference Brunner EJ, Mosdol A, Witte DR, Martikainen P, Shipley MJ, Marmot MG (2008) Dietary patterns, mortality and chronic disease risk in the Whitehall II study over 13 years of follow up. Am J Clin Nutr 87:1414–1421PubMed Brunner EJ, Mosdol A, Witte DR, Martikainen P, Shipley MJ, Marmot MG (2008) Dietary patterns, mortality and chronic disease risk in the Whitehall II study over 13 years of follow up. Am J Clin Nutr 87:1414–1421PubMed
34.
go back to reference Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J (1998) Socioeconomic factors, health behaviors, and mortality. JAMA 279:1703–1708PubMedCrossRef Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J (1998) Socioeconomic factors, health behaviors, and mortality. JAMA 279:1703–1708PubMedCrossRef
35.
go back to reference Rennie KL, McCarthy N, Yazdgerdi S, Marmot M, Brunner E (2003) Association of the metabolic syndrome with both vigorous and moderate physical activity. Int J Epidemiol 53:600–606CrossRef Rennie KL, McCarthy N, Yazdgerdi S, Marmot M, Brunner E (2003) Association of the metabolic syndrome with both vigorous and moderate physical activity. Int J Epidemiol 53:600–606CrossRef
36.
go back to reference Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef
37.
go back to reference Barker DJP (1994) Mothers, babies, and disease in later life. BMJ, London Barker DJP (1994) Mothers, babies, and disease in later life. BMJ, London
38.
go back to reference McCarron P, Okasha M, McEwen J, Davey Smith G (2002) Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland. Am J Epidemiol 155:683–687PubMedCrossRef McCarron P, Okasha M, McEwen J, Davey Smith G (2002) Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland. Am J Epidemiol 155:683–687PubMedCrossRef
39.
go back to reference Marmot MG (1997) Early life and adult disorder: research themes. Br Med Bull 53:3–9PubMed Marmot MG (1997) Early life and adult disorder: research themes. Br Med Bull 53:3–9PubMed
40.
go back to reference Rosmond R, Bjorntorp P (2000) The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 247:188–197PubMedCrossRef Rosmond R, Bjorntorp P (2000) The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 247:188–197PubMedCrossRef
41.
go back to reference Brunner EJ, Hemingway H, Walker BR et al (2002) Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome. Circulation 106:2659–2665PubMedCrossRef Brunner EJ, Hemingway H, Walker BR et al (2002) Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome. Circulation 106:2659–2665PubMedCrossRef
42.
go back to reference Hemingway H, Shipley M, Brunner E, Britton A, Malik M, Marmot MG (2005) Does autonomic function link social position to coronary risk? The Whitehall II Study. Circulation 111:3071–3077PubMedCrossRef Hemingway H, Shipley M, Brunner E, Britton A, Malik M, Marmot MG (2005) Does autonomic function link social position to coronary risk? The Whitehall II Study. Circulation 111:3071–3077PubMedCrossRef
43.
go back to reference Kuper H, Marmot M (2003) Job strain, job demands, decision latitude, and the risk of coronary heart disease within the Whitehall II study. J Epidemiol Community Health 57:147–153PubMedCrossRef Kuper H, Marmot M (2003) Job strain, job demands, decision latitude, and the risk of coronary heart disease within the Whitehall II study. J Epidemiol Community Health 57:147–153PubMedCrossRef
44.
go back to reference Chandola T, Brunner E, Marmot M (2006) Chronic stress at work and the metabolic syndrome: prospective study. BMJ 332:521–525PubMedCrossRef Chandola T, Brunner E, Marmot M (2006) Chronic stress at work and the metabolic syndrome: prospective study. BMJ 332:521–525PubMedCrossRef
45.
go back to reference Brunner EJ, Chandola T, Marmot MG (2007) Prospective effect of job strain on general and central obesity in the Whitehall II Study. Am J Epidemiol 165:828–837PubMedCrossRef Brunner EJ, Chandola T, Marmot MG (2007) Prospective effect of job strain on general and central obesity in the Whitehall II Study. Am J Epidemiol 165:828–837PubMedCrossRef
46.
go back to reference Wamala SP, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K (1999) Potential explanations for the educational gradient in coronary heart disease: a population-based case-control study of Swedish women. Am J Public Health 89:315–321PubMedCrossRef Wamala SP, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K (1999) Potential explanations for the educational gradient in coronary heart disease: a population-based case-control study of Swedish women. Am J Public Health 89:315–321PubMedCrossRef
47.
go back to reference Davey-Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J (1996) Socioeconomic differentials in mortality risk among men screened for the multiple risk factor intervention trial: I. White men. Am J Public Health 86:486–496 Davey-Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J (1996) Socioeconomic differentials in mortality risk among men screened for the multiple risk factor intervention trial: I. White men. Am J Public Health 86:486–496
48.
go back to reference Pearce N, Pomare E, Marshall S, Borman B (1993) Mortality and social class in Maori and non Maori New Zealand men: changes between 1975–7 and 1985–7. N Z Med J 106:193–196PubMed Pearce N, Pomare E, Marshall S, Borman B (1993) Mortality and social class in Maori and non Maori New Zealand men: changes between 1975–7 and 1985–7. N Z Med J 106:193–196PubMed
49.
go back to reference Siannis F, Farewell VT, Head J (2007) A multi-state model for joint modelling of terminal and non-terminal events with application to Whitehall II. Stat Med 26:426–442PubMedCrossRef Siannis F, Farewell VT, Head J (2007) A multi-state model for joint modelling of terminal and non-terminal events with application to Whitehall II. Stat Med 26:426–442PubMedCrossRef
50.
go back to reference Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335:136PubMedCrossRef Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335:136PubMedCrossRef
Metadata
Title
Biological and behavioural explanations of social inequalities in coronary heart disease: the Whitehall II study
Authors
M. G. Marmot
M. J. Shipley
H. Hemingway
J. Head
E. J. Brunner
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1144-3

Other articles of this Issue 11/2008

Diabetologia 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.